Insider Selling: Phreesia (NYSE:PHR) SVP Sells $36,024.72 in Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 2,202 shares of Phreesia stock in a transaction on Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $36,024.72. Following the completion of the sale, the senior vice president directly owned 157,349 shares of the company’s stock, valued at $2,574,229.64. The trade was a 1.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Amy Beth Vanduyn also recently made the following trade(s):

• On Thursday, January 15th, Amy Beth Vanduyn sold 687 shares of Phreesia stock. The stock was sold at an average price of $16.38, for a total value of $11,253.06.
• On Thursday, January 8th, Amy Beth Vanduyn sold 2,602 shares of Phreesia stock. The shares were sold at an average price of $17.01, for a total value of $44,260.02.

Phreesia Stock Up 1.2%

Shares of NYSE:PHR opened at $15.80 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44. The firm has a market capitalization of $952.58 million, a PE ratio of -157.98 and a beta of 0.61. The firm’s 50-day moving average is $17.81 and its two-hundred day moving average is $22.98. Phreesia, Inc. has a 1 year low of $15.40 and a 1 year high of $32.76.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 8th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.11. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The business had revenue of $120.33 million during the quarter, compared to analyst estimates of $119.98 million. During the same quarter last year, the firm posted ($0.25) earnings per share. The business’s revenue for the quarter was up 12.7% compared to the same quarter last year. Analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on PHR. Weiss Ratings reiterated a “sell (e+)” rating on shares of Phreesia in a research note on Friday, October 31st. Barclays cut their price target on Phreesia from $26.00 to $24.00 and set an “overweight” rating on the stock in a report on Tuesday, December 16th. Wells Fargo & Company assumed coverage on Phreesia in a research note on Thursday, January 8th. They issued an “overweight” rating and a $30.00 price objective for the company. Mizuho lowered their price objective on Phreesia from $36.00 to $28.00 and set an “outperform” rating for the company in a research report on Wednesday, December 10th. Finally, Canaccord Genuity Group cut their target price on shares of Phreesia from $38.00 to $33.00 and set a “buy” rating on the stock in a research note on Tuesday, December 9th. Seventeen research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $30.06.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in PHR. Squarepoint Ops LLC boosted its stake in Phreesia by 243.6% in the second quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock valued at $2,872,000 after acquiring an additional 71,553 shares in the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Phreesia by 9,375.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after purchasing an additional 3,000 shares during the last quarter. Arcadia Investment Management Corp MI lifted its holdings in shares of Phreesia by 22.3% in the 2nd quarter. Arcadia Investment Management Corp MI now owns 113,470 shares of the company’s stock valued at $3,229,000 after purchasing an additional 20,700 shares during the last quarter. Acadian Asset Management LLC boosted its position in shares of Phreesia by 61.6% in the 2nd quarter. Acadian Asset Management LLC now owns 364,194 shares of the company’s stock valued at $10,357,000 after purchasing an additional 138,877 shares during the period. Finally, Boston Partners grew its stake in Phreesia by 165.1% during the 2nd quarter. Boston Partners now owns 130,060 shares of the company’s stock worth $3,702,000 after buying an additional 81,006 shares during the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.